454 related articles for article (PubMed ID: 27078492)
1. Generating CRISPR/Cas9 Mediated Monoallelic Deletions to Study Enhancer Function in Mouse Embryonic Stem Cells.
Moorthy SD; Mitchell JA
J Vis Exp; 2016 Apr; (110):e53552. PubMed ID: 27078492
[TBL] [Abstract][Full Text] [Related]
2. Enhancers and super-enhancers have an equivalent regulatory role in embryonic stem cells through regulation of single or multiple genes.
Moorthy SD; Davidson S; Shchuka VM; Singh G; Malek-Gilani N; Langroudi L; Martchenko A; So V; Macpherson NN; Mitchell JA
Genome Res; 2017 Feb; 27(2):246-258. PubMed ID: 27895109
[TBL] [Abstract][Full Text] [Related]
3. Efficient inversions and duplications of mammalian regulatory DNA elements and gene clusters by CRISPR/Cas9.
Li J; Shou J; Guo Y; Tang Y; Wu Y; Jia Z; Zhai Y; Chen Z; Xu Q; Wu Q
J Mol Cell Biol; 2015 Aug; 7(4):284-98. PubMed ID: 25757625
[TBL] [Abstract][Full Text] [Related]
4. Use of two gRNAs for CRISPR/Cas9 improves bi-allelic homologous recombination efficiency in mouse embryonic stem cells.
Acosta S; Fiore L; Carota IA; Oliver G
Genesis; 2018 May; 56(5):e23212. PubMed ID: 29676032
[TBL] [Abstract][Full Text] [Related]
5. Large genomic fragment deletions and insertions in mouse using CRISPR/Cas9.
Zhang L; Jia R; Palange NJ; Satheka AC; Togo J; An Y; Humphrey M; Ban L; Ji Y; Jin H; Feng X; Zheng Y
PLoS One; 2015; 10(3):e0120396. PubMed ID: 25803037
[TBL] [Abstract][Full Text] [Related]
6. Advances in therapeutic CRISPR/Cas9 genome editing.
Savić N; Schwank G
Transl Res; 2016 Feb; 168():15-21. PubMed ID: 26470680
[TBL] [Abstract][Full Text] [Related]
7. Generation of α-1,3-Galactosyltransferase-Deficient Porcine Embryonic Fibroblasts by CRISPR/Cas9-Mediated Knock-in of a Small Mutated Sequence and a Targeted Toxin-Based Selection System.
Sato M; Kagoshima A; Saitoh I; Inada E; Miyoshi K; Ohtsuka M; Nakamura S; Sakurai T; Watanabe S
Reprod Domest Anim; 2015 Oct; 50(5):872-80. PubMed ID: 26138589
[TBL] [Abstract][Full Text] [Related]
8. Targeted Mutations in the Mouse via Embryonic Stem Cells.
Gertsenstein M; Mianné J; Teboul L; Nutter LMJ
Methods Mol Biol; 2020; 2066():59-82. PubMed ID: 31512207
[TBL] [Abstract][Full Text] [Related]
9. Gene Editing With CRISPR/Cas9 RNA-Directed Nuclease.
Doetschman T; Georgieva T
Circ Res; 2017 Mar; 120(5):876-894. PubMed ID: 28254804
[TBL] [Abstract][Full Text] [Related]
10. A Sox2 distal enhancer cluster regulates embryonic stem cell differentiation potential.
Zhou HY; Katsman Y; Dhaliwal NK; Davidson S; Macpherson NN; Sakthidevi M; Collura F; Mitchell JA
Genes Dev; 2014 Dec; 28(24):2699-711. PubMed ID: 25512558
[TBL] [Abstract][Full Text] [Related]
11. CRISPR/Cas9 and TALEN-mediated knock-in approaches in zebrafish.
Auer TO; Del Bene F
Methods; 2014 Sep; 69(2):142-50. PubMed ID: 24704174
[TBL] [Abstract][Full Text] [Related]
12. [High-throughput approaches to study cis-regulating elements].
España AP; Santiago-Algarra D; Pradel L; Spicuglia S
Biol Aujourdhui; 2017; 211(4):271-280. PubMed ID: 29956654
[TBL] [Abstract][Full Text] [Related]
13. Dissection of Enhancer Function Using Multiplex CRISPR-based Enhancer Interference in Cell Lines.
Carleton JB; Berrett KC; Gertz J
J Vis Exp; 2018 Jun; (136):. PubMed ID: 29912188
[TBL] [Abstract][Full Text] [Related]
14. CRISPR/Cas9 for genome editing: progress, implications and challenges.
Zhang F; Wen Y; Guo X
Hum Mol Genet; 2014 Sep; 23(R1):R40-6. PubMed ID: 24651067
[TBL] [Abstract][Full Text] [Related]
15. Super-Enhancers at the Nanog Locus Differentially Regulate Neighboring Pluripotency-Associated Genes.
Blinka S; Reimer MH; Pulakanti K; Rao S
Cell Rep; 2016 Sep; 17(1):19-28. PubMed ID: 27681417
[TBL] [Abstract][Full Text] [Related]
16. CRISPR-Cas-mediated targeted genome editing in human cells.
Yang L; Mali P; Kim-Kiselak C; Church G
Methods Mol Biol; 2014; 1114():245-67. PubMed ID: 24557908
[TBL] [Abstract][Full Text] [Related]
17. Genome engineering using CRISPR-Cas9 system.
Cong L; Zhang F
Methods Mol Biol; 2015; 1239():197-217. PubMed ID: 25408407
[TBL] [Abstract][Full Text] [Related]
18. An analysis of possible off target effects following CAS9/CRISPR targeted deletions of neuropeptide gene enhancers from the mouse genome.
Hay EA; Khalaf AR; Marini P; Brown A; Heath K; Sheppard D; MacKenzie A
Neuropeptides; 2017 Aug; 64():101-107. PubMed ID: 27866656
[TBL] [Abstract][Full Text] [Related]
19. Genome-scale deletion screening of human long non-coding RNAs using a paired-guide RNA CRISPR-Cas9 library.
Zhu S; Li W; Liu J; Chen CH; Liao Q; Xu P; Xu H; Xiao T; Cao Z; Peng J; Yuan P; Brown M; Liu XS; Wei W
Nat Biotechnol; 2016 Dec; 34(12):1279-1286. PubMed ID: 27798563
[TBL] [Abstract][Full Text] [Related]
20. Generation of a Knockout Mouse Embryonic Stem Cell Line Using a Paired CRISPR/Cas9 Genome Engineering Tool.
Wettstein R; Bodak M; Ciaudo C
Methods Mol Biol; 2016; 1341():321-43. PubMed ID: 25762293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
